| 慈濟大學 |
2003 |
Pb2+ inhibition of sympathetic alpha7-nicotinic acetylcholine receptor-mediated nitrergic neurogenic dilation in porcine basilar arteries
|
Si, Min-Liang;Lee, Tony Jer-Fu |
| 輔英科技大學 |
2016-01-26 |
PB29The development of simulation evaluation instrument (SEI) of Chinese version: Translation, reality and validity
|
胡綾真 |
| 臺北醫學大學 |
2010 |
PBA-w-Lys as sustained phenylbutyrate-releasing prodrug, accepted
|
CL, Wang;MJ, Sun;FS, Chang;SW, Yang;JF, Lian;YL, Leu;HP*, Wang |
| 臺北醫學大學 |
2010 |
PBA-w-Lys as sustained phenylbutyrate-releasing prodrug, accepted
|
Wang, CL;Sun, MJ;Chang, FS;Yang, SW;Lian, JF;Leu, YL;HP*, Wang |
| 嘉南藥理大學 |
2011 |
PBA-ω-Lys as Sustained Phenylbutyrate-Releasing Prodrug
|
Chun-Li Wang(王群力); Po-Ren Hsuen(薛博仁); Meng-Jie Sun(孫孟傑); Yann-Lii Leu (呂彥禮); Feng-Shou Chang(張峯碩); Shu-Wei Yang(楊書瑋); Jang-Feng Lian (連掌鋒); Hui-Po Wang (王惠珀) |
| 臺大學術典藏 |
2018-09-10T08:05:52Z |
PBA-ω-Lys as sustained phenylbutyrate-releasing prodrug
|
Wang, C.-L. and Hsueh, P.-R. and Sun, M.-J. and Leu, Y.-L. and Chang, F.-S. and Yang, S.-W. and Lian, J.-F. and Wang, H.-P.; PO-REN HSUEH |
| 臺大學術典藏 |
2010 |
PBA-ω-Lys as sustained phenylbutyrate-releasing prodrug
|
Wang H.-P.; Lian J.-F.; Yang S.-W.; Chang F.-S.; Leu Y.-L.; PO-REN HSUEH; Sun M.-J.; Wang C.-L.; Wang H.-P.;Lian J.-F.;Yang S.-W.;Chang F.-S.;Leu Y.-L.;Sun M.-J.;PO-REN HSUEH;Wang C.-L. |
| 臺大學術典藏 |
2010 |
PBA-ω-Lys as sustained phenylbutyrate-releasing prodrug
|
Wang C.-L.;Po-Ren Hsueh;Sun M.-J.;Leu Y.-L.;Chang F.-S.;Yang S.-W.;Lian J.-F.;Wang H.-P.; Wang C.-L.; PO-REN HSUEH; Sun M.-J.; Leu Y.-L.; Chang F.-S.; Yang S.-W.; Lian J.-F.; Wang H.-P. |
| 國立成功大學 |
2023-04 |
PbABCG1 and PbABCG2 transporters are required for the emission of floral monoterpenes in Phalaenopsis bellina
|
Chang;Ya-Lan;Huang;Li-Min;Kuo;Xuan-Zhou;Chen;You-Yi;Lin;Shao-Ting;Jeng;Mei-Fen;Yeh;Hsin-Hung;Tsai;Wen-Chieh;Chen;Hong-Hwa |
| 國立臺灣科技大學 |
2012 |
PBAT based nanocomposites for medical and industrial applications
|
Fukushima, K.;Wu, M.-H.;Bocchini, S.;Rasyida, A.;Yang, M.-C. |
